Table 1 Patient and treatment characteristics
Number of patients (n = 284) | Percentage of patients (%) | |
|---|---|---|
Age | ||
Median (range) | 60 (34–84 a) | |
Sexo | ||
Male | 256 | 89% |
Female | 28 | 11% |
ECOG | ||
0 | 164 | 58% |
1 | 104 | 37% |
2 | 16 | 5% |
Cormorbidities (CCI-HN) | ||
0 = No comorbidity | 142 | 50% |
1 = Mild | 90 | 32% |
2 = Moderate | 45 | 16% |
≥ 3 = Severe | 7 | 6% |
Localization | ||
Oral cavity | 30 | 11% |
Oropharynx | 82 | 29% |
Larynx | 134 | 47% |
Hypopharynx | 38 | 13% |
Stage | ||
III | 103 | 36% |
IVA | 144 | 51% |
IVB | 37 | 13.0% |
T Stage | ||
T1 | 13 | 5% |
T2 | 44 | 15% |
T3 | 142 | 50% |
T4 | 84 | 30% |
N Stage | ||
N0 | 96 | 34% |
N1 | 52 | 18% |
N2 | 113 | 40% |
N3 | 23 | 8% |